General

2019 Australian Microcap Investment Conference
||
Today our managing director and CEO presented at the 2019 Australian Microcap Investment Conference
continue reading
LBT wins at the Business SA Export Awards
||
LBT Innovations wins the 2019 Overall Winner for Product or Service Design at the Business SA 2019 Export Awards
continue reading
First European Sale of APAS Independence
||
We are pleased to announce the first sale of an APAS® Independence instrument in the European Union to Labor Dr Wisplinghoff
continue reading
LBT Innovations @ ExchangeSA
||
Today our managing director and CEO presented at the ExchangeSA 2019 listed companies conference in Adelaide
continue reading
MRSA Analysis Module CE Mark Registration
||
We are pleased to announce that the Declaration of Conformity for the APAS® MRSA analysis module has been completed.
continue reading
Finance News Network Interview with Brent Barnes
||
Brent Barnes, talks FY19 results and outlook and the adoption of our culture plate reading device APAS,, the sales process and regulatory approval.
continue reading
ASX Small and Mid-Cap Conference 2019
||
LBT's CEO and Managing Director Brent Barnes presenting at the ASX Small and Mid-Cap Conference in Sydney on the 5th of September 2019
continue reading
Proactive Investors Interview with Brent Barnes
||
Brent Barnes updates Proactive Investors on developments to forge ahead with product sales of its unique APAS Independence technology. 
continue reading
LBT Presentation, FNN Investor Event
||
Our CEO presents on LBT's automated plate reading device for use in laboratories, regulatory clearance in the US and the size of the market opportunity.
continue reading
APAS® INDEPENDENCE US FDA 510(k) CLEARANCE
||
A historic day as APAS Independence with Urine Analysis Module is available for sale in the United states providing access to over 1,500 potential customers.
continue reading